PHE's Bringing Our Best and Brightest to ISPOR

ISPOR's 22nd Annual International Meeting is almost here- May 20th-May 24th, 2017- and Precision Health Economics will have a very prominent presence!  

With over 25 of our experts in attendance, PHE thought leaders will be participating in a variety of scientific presentations, including a Plenary Session, 4 Issue Panels, 2 Short Courses, 2 Workshops, 2 Forums, and 8 Posters.

In addition, we'll be on the convention floor at Booth #909 and look forward to meeting colleagues there, too.

For a complete list of our scientific participation, including schedule and details, please see below:

SHORT COURSES (2):

Saturday, May 20th, 1:00pm-5:00pm

Meta-Analysis and Systematic Reviews in Comparative Effectiveness Research

PHE Faculty: Jeroen Jansen, PhD, MSc, Vice President & Chief Scientist, Evidence Synthesis and Decision Modeling, Precision Health Economics

Sunday, May 21st, 1:00pm-5:00pm

Outcomes Research Methods

PHE Faculty: Jeroen Jansen, PhD, MSc, Vice President & Chief Scientist, Evidence Synthesis and Decision Modeling, Precision Health Economics

PLENARY SESSION (1):

Monday, May 22nd, 8:30am-10:30am

First Plenary Session: Where is U.S. Health Policy Going?

PHE Participant: Peter Neumann, ScD, Principal Consultant, Precision Health Economics and Professor & Director, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center (Moderator)

ISSUE PANELS (4):

Monday, May 22nd, 11:00am-12:00pm

IP1: Future Directions for Cost Effectiveness Analysis

PHE Participant: Peter Neumann, ScD, Principal Consultant, Precision Health Economics and Professor & Director, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center (Moderator)

Monday, May 22nd, 2:15pm-3:15pm

IP4: ISPOR’s Special Task Force Report on U.S. Value Assessment Frameworks: What Does It Say and Is It Helpful?

PHE Participant: Peter Neumann, ScD, Prinicpal Consultant, Precision Health Economics and Professor & Director, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center (Moderator)

Tuesday, May 23nd, 3:45pm-4:45pm

IP13: The Complexities of Medicare Directly Negotiating Drug Prices: What Are the Pros and Cons?

PHE Participant: Dana P. Goldman, PhD, Co-Founder, Precision Health Economics and Leonard D. Schaeffer Director's Chair, Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California

Tuesday, May 223nd, 5:00pm-6:00pm

IP16: FDAMA Section 114 Has Been Replaced by Section 3037 of the Cures Act: Now What?

PHE Participant: Peter Neumann, ScD, Principal Consultant, Precision Health Economics and Professor & Director, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center (Moderator)

WORKSHOPS (2):

Monday, May 22nd, 2:15pm-3:15pm

W2: Actuarial and Health Economic Approaches to Assess Value: Speaking the Same Language or Need for Translation?

PHE Participant: Darius Lakdawalla, PhD, Chief Scientific Officer, Precision Health Economics and Professor, Quintiles Chair in Pharmaceutical Development and Regulatory Innovation, University of Southern California

Monday, May 22nd, 3:45pm-4:45pm

W5: ISPOR’s Special Task Force Report on U.S. Value Assessment Frameworks: A Deeper Dive into Its Health Economic Underpinnings

PHE Participant: Darius Lakdawalla, PhD, Chief Scientific Officer, Precision Health Economics and Professor, Quintiles Chair in Pharmaceutical Development and Regulatory Innovation, University of Southern California (Discussion Leader)

FORUM (2):

Tuesday, Mar 23rd, 6:15pm-7:15pm

F7: Performance-Based Risk Sharing Agreements- Opportunities and Challenges for Medical Devices

PHE Participant: Carla Zema, PhD, Vice President, Precision Health Economics, Los Angeles, CA, USA

Tuesday, May 23rd, 6:15pm-7:15pm

F8: Challenges in Research and Health Technology Assessment of Rare Disease Technologies

PHE Participant: Christopher Blanchette, PhD, MBA, Vice President, Evidence Straregy, Generation and Communication, Precision Health Economics and Associate Professor, Department of Public Health Sciences, University of North Carolina

POSTERS (8):

Poster Presention Session 1

Monday, May 22nd

Poster display: 8:30am-2:00pm

Author discussion: 1:00pm-2:00pm

PHP172: Patient and Hospital Characteristics Related to Liver and Kidney Donations in the United States

PHE Authors: Zacherle E, Noone JM, Blanchette CM

Poster Presentation Session II

Monday, May 22nd

Display: 3:45pm-7:45pm

Author discussion: 6:45pm-7:45pm

PMS6: Suitability of a Network Meta-Analysis of Targeted Synthetic or Biologic Therapy for Patients with Active Rheumatoid Arthritis Despite Biologic DMARDs

PHE Author: Jansen JP

PCN48: Survival Associated with COPD Among SEER-Medicare Beneficiaries with NSCLC

PHE Author: Blanchette CM

PCN50: The Effect of Cachexia on Survival in Lung Cancer Patients

PHE Authors: Noone JM, Blanchette CM

PMS21: Economics Impact of Biologic DMARD Treatment for APCA+ and RF+ Patients: A Comparison of Abatacept and TFNI Biologic DMARDs

PHE Authors: Shafrin J, Tebeka M

Poster Presentation Session III

Tuesday, May 23rd

Display: 8:30am-2:30pm

Author Discussion: 1:00pm-2:00pm

PND62: Review of the Epidemiology and Treatment Landscape in Pediatric Multiple Sclerosis in the United States

PHE Authors: D Peneva, E Druyts

Poster Presentations Session IV

Tuesday, May 23rd

Poster display: 3:45pm-7:45pm

Author discussion: 6:45pm-7:45pm

PCV58: Measuring Indirect Costs (Productivity and Caregiver Burden) in the ACC/AHA Guideline Statin Benefit Groups

PHE Authors: Mulligan K, Ton T, Yoon L, Kabiri M, Lakdawalla D

PRM160: An Outcomes Regression Approach for Indirect Comparisons of Survival Outcomes When Standard Network Meta-Analysis is Not Feasible

PHE Authors: Jansen JP, Jeffers A, Chan K, Incerti

FOR MORE INFORMATION-- VISIT THE ISPOR WEBSITE

ISPOR 22nd Annual International Meeting

May 20th-24th, 2017

Sheraton Boston & Convention Center

Boston, MA